Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Caroline White
  1. London

    A second trial looking into the long term effects of hormone replacement therapy (HRT) has been stopped early.

    The UK Medical Research Council (MRC) announced last week that a decision had been taken to halt the women's international study of long duration oestrogen after menopause (WISDOM) for “scientific and practical reasons.” The trial, which has cost £10m ($15.5m; €15.9m), was due to be completed in 2016.

    WISDOM was investigating the long term effects of oestrogen combined with progestogen and of oestrogen alone on the …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular